rs149522482

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 2P and 9B. PM1BP4_StrongBP6BS2

The NM_138694.4(PKHD1):​c.652G>A​(p.Glu218Lys) variant causes a missense change. The variant allele was found at a frequency of 0.000541 in 1,601,554 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0018 ( 0 hom., cov: 29)
Exomes 𝑓: 0.00041 ( 2 hom. )

Consequence

PKHD1
NM_138694.4 missense

Scores

1
8
10

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:4

Conservation

PhyloP100: 4.38

Publications

7 publications found
Variant links:
Genes affected
PKHD1 (HGNC:9016): (PKHD1 ciliary IPT domain containing fibrocystin/polyductin) The protein encoded by this gene is predicted to have a single transmembrane (TM)-spanning domain and multiple copies of an immunoglobulin-like plexin-transcription-factor domain. Alternative splicing results in two transcript variants encoding different isoforms. Other alternatively spliced transcripts have been described, but the full length sequences have not been determined. Several of these transcripts are predicted to encode truncated products which lack the TM and may be secreted. Mutations in this gene cause autosomal recessive polycystic kidney disease, also known as polycystic kidney and hepatic disease-1. [provided by RefSeq, Jul 2008]
PKHD1 Gene-Disease associations (from GenCC):
  • autosomal recessive polycystic kidney disease
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Myriad Women’s Health, Orphanet
  • polycystic kidney disease 4
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Laboratory for Molecular Medicine, Genomics England PanelApp
  • Caroli disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

PM1
In a hotspot region, there are 6 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 5 uncertain in NM_138694.4
BP4
Computational evidence support a benign effect (MetaRNN=0.029417843).
BP6
Variant 6-52071021-C-T is Benign according to our data. Variant chr6-52071021-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 199185.
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PKHD1NM_138694.4 linkc.652G>A p.Glu218Lys missense_variant Exon 9 of 67 ENST00000371117.8 NP_619639.3 P08F94-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PKHD1ENST00000371117.8 linkc.652G>A p.Glu218Lys missense_variant Exon 9 of 67 1 NM_138694.4 ENSP00000360158.3 P08F94-1
PKHD1ENST00000340994.4 linkc.652G>A p.Glu218Lys missense_variant Exon 9 of 61 5 ENSP00000341097.4 P08F94-2

Frequencies

GnomAD3 genomes
AF:
0.00181
AC:
275
AN:
151964
Hom.:
0
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.00522
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00216
Gnomad ASJ
AF:
0.000289
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000235
Gnomad OTH
AF:
0.00431
GnomAD2 exomes
AF:
0.000705
AC:
177
AN:
250922
AF XY:
0.000553
show subpopulations
Gnomad AFR exome
AF:
0.00517
Gnomad AMR exome
AF:
0.00148
Gnomad ASJ exome
AF:
0.000199
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000300
Gnomad OTH exome
AF:
0.000982
GnomAD4 exome
AF:
0.000409
AC:
593
AN:
1449472
Hom.:
2
Cov.:
28
AF XY:
0.000392
AC XY:
283
AN XY:
722068
show subpopulations
African (AFR)
AF:
0.00458
AC:
152
AN:
33168
American (AMR)
AF:
0.00145
AC:
65
AN:
44696
Ashkenazi Jewish (ASJ)
AF:
0.000153
AC:
4
AN:
26068
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39624
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
85982
European-Finnish (FIN)
AF:
0.0000187
AC:
1
AN:
53410
Middle Eastern (MID)
AF:
0.00139
AC:
8
AN:
5736
European-Non Finnish (NFE)
AF:
0.000265
AC:
292
AN:
1100814
Other (OTH)
AF:
0.00117
AC:
70
AN:
59974
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.462
Heterozygous variant carriers
0
27
55
82
110
137
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00180
AC:
274
AN:
152082
Hom.:
0
Cov.:
29
AF XY:
0.00159
AC XY:
118
AN XY:
74340
show subpopulations
African (AFR)
AF:
0.00518
AC:
215
AN:
41514
American (AMR)
AF:
0.00216
AC:
33
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.000289
AC:
1
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5130
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4804
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10598
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000235
AC:
16
AN:
67974
Other (OTH)
AF:
0.00426
AC:
9
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
14
28
43
57
71
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000843
Hom.:
0
Bravo
AF:
0.00214
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.00590
AC:
26
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000667
AC:
81
EpiCase
AF:
0.000436
EpiControl
AF:
0.000296

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2Benign:1
Mar 08, 2023
Mayo Clinic Laboratories, Mayo Clinic
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

BS1, PP4, PM3 -

Sep 18, 2018
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PKHD1: BS2 -

Autosomal recessive polycystic kidney disease Uncertain:1Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 07, 2017
Natera, Inc.
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Polycystic kidney disease 4 Uncertain:1
Nov 04, 2021
Myriad Genetics, Inc.
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

NM_138694.3(PKHD1):c.652G>A(E218K) is a missense variant classified as a variant of uncertain significance in the context of autosomal recessive polycystic kidney disease, PKHD1-related. E218K has been observed in cases with relevant disease (PMID: 16133180, 27225849, 25701400). Functional assessments of this variant are not available in the literature. E218K has been observed in population frequency databases (gnomAD: AFR 0.51%). In summary, there is insufficient evidence to classify NM_138694.3(PKHD1):c.652G>A(E218K) as pathogenic or benign. Please note: this variant was assessed in the context of healthy population screening. -

Autosomal dominant polycystic liver disease Benign:1
Sep 01, 2021
Laboratory of Gastroenterology and Hepatology, Radboud University Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:research

- -

PKHD1-related disorder Benign:1
May 21, 2021
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.061
T
BayesDel_noAF
Pathogenic
0.14
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Benign
0.26
T;.
Eigen
Benign
-0.33
Eigen_PC
Benign
-0.24
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.89
D;D
M_CAP
Uncertain
0.092
D
MetaRNN
Benign
0.029
T;T
MetaSVM
Benign
-0.71
T
MutationAssessor
Uncertain
2.4
M;M
PhyloP100
4.4
PrimateAI
Uncertain
0.54
T
PROVEAN
Benign
-1.5
N;N
REVEL
Uncertain
0.53
Sift
Uncertain
0.0090
D;D
Sift4G
Benign
0.076
T;T
Polyphen
0.19
B;B
Vest4
0.95
MVP
0.93
MPC
0.11
ClinPred
0.036
T
GERP RS
4.3
Varity_R
0.13
gMVP
0.84
Mutation Taster
=59/41
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
Splicevardb
2.0
SpliceAI score (max)
0.19
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs149522482; hg19: chr6-51935819; API